外陰膣カンジダ症治療薬の世界市場規模・シェア・産業動向分析レポート：流通チャネル別、投与経路別（経口・静脈内・局所）、薬物クラス別、地域別展望・予測、2022年～2028年版

外陰膣カンジダ症治療薬の世界市場規模は、2028年までに13億米ドルに達し、予測期間中にCAGR4.6%の市場成長率で上昇すると予測されています。

この疾患では、患者の意識が非常に重要です。外陰膣カンジダ症は生命を脅かすものではありませんが、悪化すると恥ずかしさから性行為から遠ざかってしまう可能性があるため、長期にわたって適切な薬物治療を受けることが不可欠です。膣の不快感の原因としては、悪性腫瘍、虐待、外傷、炎症性腸疾患、性感染症、免疫疾患などが考えられます。膣の不快感の原因は、悪性腫瘍、虐待、外傷、炎症性腸疾患、性感染症、免疫疾患などです。

膣内の痛み、赤み、腫れを感じたら、外陰膣カンジダ症の診断を受けるべきです。外陰膣カンジダ症は、膣のpHが4.5と正常な状態であることが条件とされています。10％のKOHを湿式で使用することで、仮性菌や酵母を隠している細胞を破壊し、菌糸や酵母の可視性を向上させることができます。外陰膣カンジダ症の症状を有するすべての女性は、KOH製剤を用いた湿潤マウントの検査を受け、期限内に治療を受けることが重要です。

COVID-19の影響解析

新型コロナウイルスの世界の蔓延は、外陰膣カンジダ症治療薬市場の成長に若干の影響を与えています。外陰膣カンジダ症治療薬の需要は、COVID-19に罹患した患者のカンジダ症有病率が上昇したため、高くなりました。これは、特に病院に入院していた人たちの間で、ヘルスケア関連感染や血流感染などが増加しているためです。これらの要素により、外陰膣カンジダ症市場は2020年第1四半期以降急速に回復し、さらに今後も成長を続けると予測されます。

市場の成長要因

研究開発と製品ポートフォリオの拡大への支出の増加

市場では、安全かつ有効な様々な抗真菌剤のイントロダクションが行われています。有効な抗真菌剤としては、テルビナフィン、フルコナゾール、イトラコナゾールがあります。製薬業界は、抗感染症薬の製品ポートフォリオを拡大するために、研究開発への支出を増やしています。市場関係者の多くは、外陰膣カンジダ症などの真菌感染症を治療するために、免疫力の低い患者に対する効果的な治療薬の開発に注力しています。

糖尿病罹患率の上昇

糖尿病の有病率は、世界中で増加の一途をたどっています。WHOのデータによると、1980年の糖尿病患者数は約1億800万人でしたが、2014年には4億2200万人に増加しました。高所得国に比べ、低所得国や中所得国での有病率がより急速に増加しています。糖尿病は、脳卒中や心不全、失明、腎不全など、さまざまな深刻な問題を引き起こす原因の一つとなっています。2014年には、18歳以上の成人の約8.5%が糖尿病であるとされています。世界中で糖尿病の有病率が高まっていることから、外陰膣カンジダ症の症例も増加すると予測されています。このことは、今後数年間における外陰膣カンジダ症治療薬の市場成長をもたらすと思われます。

市場抑制要因

フルコナゾールなどの医薬品の摂取による副作用

フルコナゾールなどの医薬品は、外陰膣カンジダ症などのカンジダ真菌感染症を治療するために処方される抗真菌薬です。フルコナゾールの摂取により、各種血液希釈剤、抗生物質、鎮静剤、利尿剤、抗けいれん剤、その他様々な薬と薬物相互作用を起こす可能性があります。また、医薬品に記載されている様々な注意事項は、肝障害やその他の疾患を有する個人に適用され、そのような条件を消費することで副作用につながる可能性があります。

流通経路の展望

外陰膣カンジダ症治療薬市場は、流通チャネル別に、病院薬局、小売薬局、オンライン薬局に分けられます。2021年、外陰膣カンジダ症治療市場で最も高い収益シェアを示したのは、小売薬局のセグメントです。この病気の治療には、短期的だけでなく長期的な薬のサポートが必要であり、それが小売薬局からの治療薬の販売を高めています。

投与経路の展望

外陰膣カンジダ症治療薬市場は、投与経路別に経口剤、静脈内投与、外用剤に分類されます。2021年の外陰膣カンジダ症治療薬市場では、外用剤が大きな収益シェアを占めています。これは、処方箋製剤やOTCなどの外用剤が利用可能であることに起因しています。外用OTCにはミコナゾールクリーム、チオコナゾール軟膏、クロトリマゾールクリームなどがあり、処方製剤にはテルコナゾールクリームやブトコナゾールクリームなどがあります。

薬物クラスの展望

外陰膣カンジダ症治療薬市場は、薬剤クラスに基づいて、クロトリマゾール、ナイスタチン、フルコナゾール、ケトコナゾール、テルビナフィン、テルコナゾール、その他に区分されます。2021年には、フルコナゾールセグメントが外陰膣カンジダ症治療薬市場を独占し、最大の収益シェアを獲得しました。真菌疾患は、特定の理由で公衆衛生に重大な脅威を与え、そのため、世界中の市場プレーヤーは、フルコナゾールの臨床使用の研究開発に焦点を当てています。

地域別展望

地域別に見ると、外陰膣カンジダ症治療薬市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。北米地域は、2021年に最大の収益シェアを獲得し、外陰膣カンジダ症治療市場をリードしました。同地域が市場で優位に立つ主な要因は、ジョンソン・エンド・ジョンソンサービス株式会社、ファイザー株式会社などの市場プレイヤーの存在です。さらに、この地域の市場は、北米諸国における外陰膣カンジダ症の症例増加につながる可能性のある糖尿病の有病率の上昇によって拡大しています。

目次

第1章 市場の範囲と調査手法

• 市場の定義
• 目的
• 市場規模
• セグメンテーション
  • 外陰膣カンジダ症治療薬の世界市場：流通経路別
  • 外陰膣カンジダ症治療薬の世界市場：投与経路別
  • 外陰膣カンジダ症治療薬の世界市場：薬物クラス別
  • 外陰膣カンジダ症治療薬の世界市場：地域別
• 調査手法

第2章 市場概要

• イントロダクション
  • 概要説明
    • 市場の構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因

第3章 外陰膣カンジダ症治療薬の世界市場：流通チャネル別

• 小売薬局の世界市場：地域別
• 病院内薬局の世界市場：地域別
• オンライン薬局の世界市場：地域別

第4章 外陰膣カンジダ症治療薬の世界市場：投与経路別

• 経口剤の世界市場：地域別
• 静脈注射の世界市場：地域別
• 外用薬の世界市場：地域別

第5章 外陰膣カンジダ症治療薬の世界市場：薬物クラス別

• フルコナゾールの世界市場：地域別
• クロトリマゾールの世界市場：地域別
• テルコナゾールの世界市場：地域別
• テルビナフィンの世界市場：地域別
• ナイスタチンの世界市場：地域別
• ケトコナゾールの世界市場：地域別
• 地域別世界のその他市場

第6章 外陰膣カンジダ症治療薬の世界市場：地域別市場

• 北米
  • 北米の外陰膣カンジダ症治療薬の国別市場
    • 米国
    • カナダ
    • メキシコ
    • その他北米地域
• 欧州
  • 欧州の外陰膣カンジダ症治療薬の国別市場
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • イタリア
    • その他欧州
• アジア太平洋地域
  • アジア太平洋地域の外陰膣カンジダ症治療薬の国別市場
    • 中国
    • 日本
    • インド
    • 韓国
    • シンガポール
    • マレーシア
    • その他アジア太平洋地域
• LAMEA
  • LAMEAの外陰膣カンジダ症治療薬の国別市場
    • ブラジル
    • アルゼンチン
    • UAE
    • サウジアラビア
    • 南アフリカ共和国
    • ナイジェリア
    • その他のLAMEA

第7章 企業プロファイル

• Bayer AG
• Pfizer, Inc.
• Bristol Myers Squibb Company
• Astellas Pharma, Inc.
• Mycovia Pharmaceuticals, Inc.（NovaQuest Capital Management, LLC）
• Basilea Pharmaceutica Ltd.
• Scynexis, Inc.
• Grupo Ferrer Internacional S.A

LIST OF TABLES

• TABLE 1 Global Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 2 Global Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 3 Global Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 4 Global Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 5 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
• TABLE 6 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
• TABLE 7 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
• TABLE 8 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
• TABLE 9 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
• TABLE 10 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
• TABLE 11 Global Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 12 Global Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 13 Global Oral Market by Region, 2018 - 2021, USD Million
• TABLE 14 Global Oral Market by Region, 2022 - 2028, USD Million
• TABLE 15 Global Intravenous Market by Region, 2018 - 2021, USD Million
• TABLE 16 Global Intravenous Market by Region, 2022 - 2028, USD Million
• TABLE 17 Global Topical Market by Region, 2018 - 2021, USD Million
• TABLE 18 Global Topical Market by Region, 2022 - 2028, USD Million
• TABLE 19 Global Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 20 Global Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 21 Global Fluconazole Market by Region, 2018 - 2021, USD Million
• TABLE 22 Global Fluconazole Market by Region, 2022 - 2028, USD Million
• TABLE 23 Global Clotrimazole Market by Region, 2018 - 2021, USD Million
• TABLE 24 Global Clotrimazole Market by Region, 2022 - 2028, USD Million
• TABLE 25 Global Terconazole Market by Region, 2018 - 2021, USD Million
• TABLE 26 Global Terconazole Market by Region, 2022 - 2028, USD Million
• TABLE 27 Global Terbinafine Market by Region, 2018 - 2021, USD Million
• TABLE 28 Global Terbinafine Market by Region, 2022 - 2028, USD Million
• TABLE 29 Global Nystatin Market by Region, 2018 - 2021, USD Million
• TABLE 30 Global Nystatin Market by Region, 2022 - 2028, USD Million
• TABLE 31 Global Ketoconazole Market by Region, 2018 - 2021, USD Million
• TABLE 32 Global Ketoconazole Market by Region, 2022 - 2028, USD Million
• TABLE 33 Global Others Market by Region, 2018 - 2021, USD Million
• TABLE 34 Global Others Market by Region, 2022 - 2028, USD Million
• TABLE 35 Global Vulvovaginal Candidiasis Treatment Market by Region, 2018 - 2021, USD Million
• TABLE 36 Global Vulvovaginal Candidiasis Treatment Market by Region, 2022 - 2028, USD Million
• TABLE 37 North America Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 38 North America Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 39 North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 40 North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 41 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
• TABLE 42 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
• TABLE 43 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
• TABLE 44 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
• TABLE 45 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
• TABLE 46 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
• TABLE 47 North America Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 48 North America Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 49 North America Oral Market by Country, 2018 - 2021, USD Million
• TABLE 50 North America Oral Market by Country, 2022 - 2028, USD Million
• TABLE 51 North America Intravenous Market by Country, 2018 - 2021, USD Million
• TABLE 52 North America Intravenous Market by Country, 2022 - 2028, USD Million
• TABLE 53 North America Topical Market by Country, 2018 - 2021, USD Million
• TABLE 54 North America Topical Market by Country, 2022 - 2028, USD Million
• TABLE 55 North America Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 56 North America Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 57 North America Fluconazole Market by Country, 2018 - 2021, USD Million
• TABLE 58 North America Fluconazole Market by Country, 2022 - 2028, USD Million
• TABLE 59 North America Clotrimazole Market by Country, 2018 - 2021, USD Million
• TABLE 60 North America Clotrimazole Market by Country, 2022 - 2028, USD Million
• TABLE 61 North America Terconazole Market by Country, 2018 - 2021, USD Million
• TABLE 62 North America Terconazole Market by Country, 2022 - 2028, USD Million
• TABLE 63 North America Terbinafine Market by Country, 2018 - 2021, USD Million
• TABLE 64 North America Terbinafine Market by Country, 2022 - 2028, USD Million
• TABLE 65 North America Nystatin Market by Country, 2018 - 2021, USD Million
• TABLE 66 North America Nystatin Market by Country, 2022 - 2028, USD Million
• TABLE 67 North America Ketoconazole Market by Country, 2018 - 2021, USD Million
• TABLE 68 North America Ketoconazole Market by Country, 2022 - 2028, USD Million
• TABLE 69 North America Others Market by Country, 2018 - 2021, USD Million
• TABLE 70 North America Others Market by Country, 2022 - 2028, USD Million
• TABLE 71 North America Vulvovaginal Candidiasis Treatment Market by Country, 2018 - 2021, USD Million
• TABLE 72 North America Vulvovaginal Candidiasis Treatment Market by Country, 2022 - 2028, USD Million
• TABLE 73 US Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 74 US Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 75 US Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 76 US Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 77 US Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 78 US Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 79 US Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 80 US Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 81 Canada Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 82 Canada Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 83 Canada Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 84 Canada Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 85 Canada Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 86 Canada Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 87 Canada Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 88 Canada Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 89 Mexico Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 90 Mexico Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 91 Mexico Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 92 Mexico Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 93 Mexico Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 94 Mexico Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 95 Mexico Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 96 Mexico Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 97 Rest of North America Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 98 Rest of North America Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 99 Rest of North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 100 Rest of North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 101 Rest of North America Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 102 Rest of North America Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 103 Rest of North America Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 104 Rest of North America Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 105 Europe Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 106 Europe Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 107 Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 108 Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 109 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
• TABLE 110 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
• TABLE 111 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
• TABLE 112 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
• TABLE 113 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
• TABLE 114 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
• TABLE 115 Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 116 Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 117 Europe Oral Market by Country, 2018 - 2021, USD Million
• TABLE 118 Europe Oral Market by Country, 2022 - 2028, USD Million
• TABLE 119 Europe Intravenous Market by Country, 2018 - 2021, USD Million
• TABLE 120 Europe Intravenous Market by Country, 2022 - 2028, USD Million
• TABLE 121 Europe Topical Market by Country, 2018 - 2021, USD Million
• TABLE 122 Europe Topical Market by Country, 2022 - 2028, USD Million
• TABLE 123 Europe Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 124 Europe Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 125 Europe Fluconazole Market by Country, 2018 - 2021, USD Million
• TABLE 126 Europe Fluconazole Market by Country, 2022 - 2028, USD Million
• TABLE 127 Europe Clotrimazole Market by Country, 2018 - 2021, USD Million
• TABLE 128 Europe Clotrimazole Market by Country, 2022 - 2028, USD Million
• TABLE 129 Europe Terconazole Market by Country, 2018 - 2021, USD Million
• TABLE 130 Europe Terconazole Market by Country, 2022 - 2028, USD Million
• TABLE 131 Europe Terbinafine Market by Country, 2018 - 2021, USD Million
• TABLE 132 Europe Terbinafine Market by Country, 2022 - 2028, USD Million
• TABLE 133 Europe Nystatin Market by Country, 2018 - 2021, USD Million
• TABLE 134 Europe Nystatin Market by Country, 2022 - 2028, USD Million
• TABLE 135 Europe Ketoconazole Market by Country, 2018 - 2021, USD Million
• TABLE 136 Europe Ketoconazole Market by Country, 2022 - 2028, USD Million
• TABLE 137 Europe Others Market by Country, 2018 - 2021, USD Million
• TABLE 138 Europe Others Market by Country, 2022 - 2028, USD Million
• TABLE 139 Europe Vulvovaginal Candidiasis Treatment Market by Country, 2018 - 2021, USD Million
• TABLE 140 Europe Vulvovaginal Candidiasis Treatment Market by Country, 2022 - 2028, USD Million
• TABLE 141 Germany Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 142 Germany Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 143 Germany Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 144 Germany Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 145 Germany Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 146 Germany Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 147 Germany Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 148 Germany Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 149 UK Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 150 UK Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 151 UK Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 152 UK Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 153 UK Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 154 UK Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 155 UK Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 156 UK Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 157 France Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 158 France Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 159 France Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 160 France Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 161 France Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 162 France Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 163 France Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 164 France Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 165 Russia Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 166 Russia Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 167 Russia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 168 Russia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 169 Russia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 170 Russia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 171 Russia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 172 Russia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 173 Spain Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 174 Spain Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 175 Spain Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 176 Spain Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 177 Spain Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 178 Spain Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 179 Spain Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 180 Spain Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 181 Italy Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 182 Italy Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 183 Italy Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 184 Italy Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 185 Italy Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 186 Italy Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 187 Italy Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 188 Italy Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 189 Rest of Europe Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 190 Rest of Europe Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 191 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 192 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 193 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 194 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 195 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 196 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 197 Asia Pacific Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 198 Asia Pacific Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 199 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 200 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 201 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
• TABLE 202 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
• TABLE 203 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
• TABLE 204 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
• TABLE 205 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
• TABLE 206 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
• TABLE 207 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 208 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 209 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
• TABLE 210 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
• TABLE 211 Asia Pacific Intravenous Market by Country, 2018 - 2021, USD Million
• TABLE 212 Asia Pacific Intravenous Market by Country, 2022 - 2028, USD Million
• TABLE 213 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
• TABLE 214 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
• TABLE 215 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 216 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 217 Asia Pacific Fluconazole Market by Country, 2018 - 2021, USD Million
• TABLE 218 Asia Pacific Fluconazole Market by Country, 2022 - 2028, USD Million
• TABLE 219 Asia Pacific Clotrimazole Market by Country, 2018 - 2021, USD Million
• TABLE 220 Asia Pacific Clotrimazole Market by Country, 2022 - 2028, USD Million
• TABLE 221 Asia Pacific Terconazole Market by Country, 2018 - 2021, USD Million
• TABLE 222 Asia Pacific Terconazole Market by Country, 2022 - 2028, USD Million
• TABLE 223 Asia Pacific Terbinafine Market by Country, 2018 - 2021, USD Million
• TABLE 224 Asia Pacific Terbinafine Market by Country, 2022 - 2028, USD Million
• TABLE 225 Asia Pacific Nystatin Market by Country, 2018 - 2021, USD Million
• TABLE 226 Asia Pacific Nystatin Market by Country, 2022 - 2028, USD Million
• TABLE 227 Asia Pacific Ketoconazole Market by Country, 2018 - 2021, USD Million
• TABLE 228 Asia Pacific Ketoconazole Market by Country, 2022 - 2028, USD Million
• TABLE 229 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
• TABLE 230 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
• TABLE 231 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Country, 2018 - 2021, USD Million
• TABLE 232 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Country, 2022 - 2028, USD Million
• TABLE 233 China Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 234 China Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 235 China Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 236 China Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 237 China Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 238 China Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 239 China Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 240 China Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 241 Japan Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 242 Japan Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 243 Japan Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 244 Japan Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 245 Japan Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 246 Japan Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 247 Japan Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 248 Japan Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 249 India Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 250 India Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 251 India Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 252 India Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 253 India Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 254 India Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 255 India Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 256 India Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 257 South Korea Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 258 South Korea Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 259 South Korea Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 260 South Korea Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 261 South Korea Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 262 South Korea Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 263 South Korea Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 264 South Korea Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 265 Singapore Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 266 Singapore Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 267 Singapore Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 268 Singapore Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 269 Singapore Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 270 Singapore Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 271 Singapore Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 272 Singapore Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 273 Malaysia Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 274 Malaysia Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 275 Malaysia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 276 Malaysia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 277 Malaysia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 278 Malaysia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 279 Malaysia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 280 Malaysia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 281 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 282 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 283 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 284 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 285 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 286 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 287 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 288 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 289 LAMEA Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 290 LAMEA Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 291 LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 292 LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 293 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
• TABLE 294 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
• TABLE 295 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
• TABLE 296 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
• TABLE 297 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
• TABLE 298 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
• TABLE 299 LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 300 LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 301 LAMEA Oral Market by Country, 2018 - 2021, USD Million
• TABLE 302 LAMEA Oral Market by Country, 2022 - 2028, USD Million
• TABLE 303 LAMEA Intravenous Market by Country, 2018 - 2021, USD Million
• TABLE 304 LAMEA Intravenous Market by Country, 2022 - 2028, USD Million
• TABLE 305 LAMEA Topical Market by Country, 2018 - 2021, USD Million
• TABLE 306 LAMEA Topical Market by Country, 2022 - 2028, USD Million
• TABLE 307 LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 308 LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 309 LAMEA Fluconazole Market by Country, 2018 - 2021, USD Million
• TABLE 310 LAMEA Fluconazole Market by Country, 2022 - 2028, USD Million
• TABLE 311 LAMEA Clotrimazole Market by Country, 2018 - 2021, USD Million
• TABLE 312 LAMEA Clotrimazole Market by Country, 2022 - 2028, USD Million
• TABLE 313 LAMEA Terconazole Market by Country, 2018 - 2021, USD Million
• TABLE 314 LAMEA Terconazole Market by Country, 2022 - 2028, USD Million
• TABLE 315 LAMEA Terbinafine Market by Country, 2018 - 2021, USD Million
• TABLE 316 LAMEA Terbinafine Market by Country, 2022 - 2028, USD Million
• TABLE 317 LAMEA Nystatin Market by Country, 2018 - 2021, USD Million
• TABLE 318 LAMEA Nystatin Market by Country, 2022 - 2028, USD Million
• TABLE 319 LAMEA Ketoconazole Market by Country, 2018 - 2021, USD Million
• TABLE 320 LAMEA Ketoconazole Market by Country, 2022 - 2028, USD Million
• TABLE 321 LAMEA Others Market by Country, 2018 - 2021, USD Million
• TABLE 322 LAMEA Others Market by Country, 2022 - 2028, USD Million
• TABLE 323 LAMEA Vulvovaginal Candidiasis Treatment Market by Country, 2018 - 2021, USD Million
• TABLE 324 LAMEA Vulvovaginal Candidiasis Treatment Market by Country, 2022 - 2028, USD Million

• TABLE 325 Brazil Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 326 Brazil Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 327 Brazil Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 328 Brazil Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 329 Brazil Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 330 Brazil Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 331 Brazil Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 332 Brazil Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 333 Argentina Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 334 Argentina Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 335 Argentina Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 336 Argentina Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 337 Argentina Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 338 Argentina Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 339 Argentina Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 340 Argentina Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 341 UAE Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 342 UAE Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 343 UAE Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 344 UAE Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 345 UAE Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 346 UAE Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 347 UAE Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 348 UAE Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 349 Saudi Arabia Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 350 Saudi Arabia Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 351 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 352 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 353 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 354 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 355 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 356 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 357 South Africa Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 358 South Africa Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 359 South Africa Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 360 South Africa Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 361 South Africa Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 362 South Africa Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 363 South Africa Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 364 South Africa Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 365 Nigeria Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 366 Nigeria Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 367 Nigeria Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 368 Nigeria Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 369 Nigeria Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 370 Nigeria Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 371 Nigeria Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 372 Nigeria Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 373 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
• TABLE 374 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
• TABLE 375 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
• TABLE 376 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
• TABLE 377 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
• TABLE 378 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
• TABLE 379 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
• TABLE 380 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
• TABLE 381 Key Information - Bayer AG
• TABLE 382 Key Information - Pfizer, Inc.
• TABLE 383 Key Information - Bristol Myers Squibb Company
• TABLE 384 key information - Astellas Pharma, Inc.
• TABLE 385 Key Information - Mycovia Pharmaceuticals, Inc.
• TABLE 386 Key Information - Basilea Pharmaceutica Ltd.
• TABLE 387 Key Information - Scynexis, Inc.
• TABLE 388 Key Information - Grupo Ferrer Internacional S.A.

List of Figures

• FIG 1 Methodology for the research
• FIG 2 Global Vulvovaginal Candidiasis Treatment Market Share by Distribution Channel, 2021
• FIG 3 Global Vulvovaginal Candidiasis Treatment Market Share by Distribution Channel, 2028
• FIG 4 Global Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2028, USD Million
• FIG 5 Global Vulvovaginal Candidiasis Treatment Market Share by Route of Administration, 2021
• FIG 6 Global Vulvovaginal Candidiasis Treatment Market Share by Route of Administration, 2028
• FIG 7 Global Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2028, USD Million
• FIG 8 Global Vulvovaginal Candidiasis Treatment Market Share by Drug Class, 2021
• FIG 9 Global Vulvovaginal Candidiasis Treatment Market Share by Drug Class, 2028
• FIG 10 Global Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2028, USD Million
• FIG 11 Global Vulvovaginal Candidiasis Treatment Market Share by Region, 2021
• FIG 12 Global Vulvovaginal Candidiasis Treatment Market Share by Region, 2028
• FIG 13 Global Vulvovaginal Candidiasis Treatment Market by Region, 2018 - 2028, USD Million

The Global Vulvovaginal Candidiasis Treatment Market size is expected to reach $1.3 billion by 2028, rising at a market growth of 4.6% CAGR during the forecast period.

Vulvovaginal Candidiasis is generally caused due to candida Albicans or candida species or yeast. Some of the symptoms of vulvovaginal candidiasis include abnormal vaginal discharge, vaginal soreness, dyspareunia, external dysuria, and pruritis. As per the data provided by the Centers for Disease Control and Prevention, around 75% of women are predicted to have vulvovaginal candidiasis at least one time and 40%-45% of women may have the condition two or more times. The condition is classified as complicated or uncomplicated on the basis of clinical presentation, host factors, microbiology, and response to therapy.

The condition generally rises the need to consider a gynecologist or nurse practitioner. Vulvovaginal Candidiasis can be diagnosed and managed by antifungal medications. Although vulvovaginal candidiasis could be treated in a few days, in cases of complicated situations the treatment could be for a longer period.

Patient awareness is very crucial in this condition. Though vulvovaginal candidiasis is not life-threatening it is essential to have adequate medication over time as it may become worse and lead to withdrawal from sexual activities out of embarrassment. Malignancy, abuse, trauma, inflammatory bowel disease, sexual transmission of infections, and immune disease could be some of the reasons for vaginal discomfort. The patients must undergo a complete and careful physical test, and proper ancillary testing to know about the exact reason for the condition for further treatment.

One should undergo the diagnosis of vulvovaginal candidiasis if the person feels pain, redness, or swelling in the vaginal area. The condition of vulvovaginal candidiasis is linked to normal vaginal pH which is 4.5. Using 10% of KOH in wet preparations helps in improving the visualization of mycelia and yeast via disrupting cellular material which may hide the pseudohyphae or yeast. It is important for all women having symptoms of vulvovaginal candidiasis to undergo an examination of the wet mount with KOH preparation and get treatment on time.

COVID-19 Impact Analysis

The widespread novel coronavirus all over the world has slightly impacted the growth of the vulvovaginal candidiasis treatment market. The demand for drugs for vulvovaginal candidiasis was high due to the rising prevalence of candidiasis among patients who have suffered from COVID-19. This is because of the rise in healthcare-associated infections and bloodstream infections, especially among those who were admitted to hospitals. Owing to all these elements, the vulvovaginal candidiasis market has quickly recovered after the first quarter of 2020 and is further anticipated to continue to grow.

Market Growth Factor

Growing spending on research & development and expansion of product portfolio

The market has been witnessing the introduction of various safe & effective antifungal agents. Some of the effective antifungal agents available in the market are terbinafine, fluconazole, and itraconazole. The pharmaceutical industries are increasing the expenditure on research & development intending to expand their product portfolio for anti-infective drugs. Most of the market players are focusing on the development of effective therapeutic agents for patients with weak immunity systems to cure fungal infections such as vulvovaginal candidiasis.

Rising prevalence of diabetes

The prevalence of diabetes is growing continuously all over the world. According to the data provided by WHO, in 1980, patients with diabetes was around 108 million, which rose to 422 million in 2014. The prevalence has been growing more rapidly in low-income and middle-income nations as compared to high-income nations. Diabetes is one of the reasons for various serious issues such as stroke, heart failure, blindness, kidney failure, and others. In 2014, about 8.5% of adults above the age of 18 were diabetic. As the prevalence of diabetes across the world is growing, the cases of vulvovaginal candidiasis are also predicted to increase. This would result in market growth for the vulvovaginal candidiasis treatment in the upcoming years.

Market Restraining Factor

Side effects of consumption of medicines such as fluconazole

Medicines such as fluconazole are antifungal medications prescribed to cure candida fungal infections such as vulvovaginal candidiasis. The consumption of fluconazole may lead to drug interaction with various blood thinners, antibiotics, sedatives, diuretics, antiseizure, and various other medications. Also, various cautions mentioned on the medicines are applied to individuals having liver disorders or any other diseases which could lead to the side effect of consuming such conditions.

Distribution Channel Outlook

On the basis of distribution channel, the vulvovaginal candidiasis treatment market is divided into hospital pharmacy, retail pharmacy and online pharmacy. In 2021, the retail pharmacy segment witnessed the highest revenue share in the vulvovaginal candidiasis treatment market. The disease treatment takes short as well as long-term support of medications which raises the sale of treatment drugs from retail pharmacies.

Route of Administration Outlook

By route of administration, the vulvovaginal candidiasis treatment market is fragmented into oral, intravenous and topical. The topical segment covered a significant revenue share in the vulvovaginal candidiasis treatment market in 2021. This is attributable to the availability of topical products such as prescription formulations and over-the-counter. Topical OTCs include Miconazole cream, Tioconazole ointment, and Clotrimazole cream and prescription formulations include Terconazole cream and Butoconazole cream.

Drug Class Outlook

Based on drug class, the vulvovaginal candidiasis treatment market is segmented into clotrimazole, nystatin, fluconazole, ketoconazole, terbinafine, terconazole and others. In 2021, the fluconazole segment dominated the vulvovaginal candidiasis treatment market with the maximum revenue share. Fungal diseases pose a crucial threat to public health for certain reasons, due to which the market players across the globe are focused on research & development of clinical use of fluconazole.

Regional Outlook

Region wise, the vulvovaginal candidiasis treatment market analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region led the vulvovaginal candidiasis treatment market by generating the maximum revenue share in 2021. The main factor resulting in the region's dominance in the market is the presence of market players such as Johnson & Johnson Services Inc., Pfizer Inc., and others. Moreover, the regional market is expanding due to the rising prevalence of diabetes in the region, which may lead to increased cases of vulvovaginal candidiasis in the North American nations.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Bristol Myers Squibb Company, Pfizer, Inc., Astellas Pharma, Inc., Mycovia Pharmaceuticals, Inc. (NovaQuest Capital Management,LLC), Basilea Pharmaceutica Ltd., Scynexis, Inc. and Grupo Ferrer Internacional S.A.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

By Route of Administration

• Oral
• Intravenous
• Topical

By Drug Class

• Fluconazole
• Clotrimazole
• Terconazole
• Terbinafine
• Nystatin
• Ketoconazole
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Bayer AG
• Bristol Myers Squibb Company
• Pfizer, Inc.
• Astellas Pharma, Inc.
• Mycovia Pharmaceuticals, Inc. (NovaQuest Capital Management,LLC)
• Basilea Pharmaceutica Ltd.
• Scynexis, Inc.
• Grupo Ferrer Internacional S.A.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Vulvovaginal Candidiasis Treatment Market, by Distribution Channel
  • 1.4.2 Global Vulvovaginal Candidiasis Treatment Market, by Route of Administration
  • 1.4.3 Global Vulvovaginal Candidiasis Treatment Market, by Drug Class
  • 1.4.4 Global Vulvovaginal Candidiasis Treatment Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market Overview

• 2.1 Introduction
  • 2.1.1 Overview
    • 2.1.1.1 Market Composition & Scenario
• 2.2 Key Factors Impacting the Market
  • 2.2.1 Market Drivers
  • 2.2.2 Market Restraints

Chapter 3. Global Vulvovaginal Candidiasis Treatment Market by Distribution Channel

• 3.1 Global Retail Pharmacy Market by Region
• 3.2 Global Hospital Pharmacy Market by Region
• 3.3 Global Online Pharmacy Market by Region

Chapter 4. Global Vulvovaginal Candidiasis Treatment Market by Route of Administration

• 4.1 Global Oral Market by Region
• 4.2 Global Intravenous Market by Region
• 4.3 Global Topical Market by Region

Chapter 5. Global Vulvovaginal Candidiasis Treatment Market by Drug Class

• 5.1 Global Fluconazole Market by Region
• 5.2 Global Clotrimazole Market by Region
• 5.3 Global Terconazole Market by Region
• 5.4 Global Terbinafine Market by Region
• 5.5 Global Nystatin Market by Region
• 5.6 Global Ketoconazole Market by Region
• 5.7 Global Others Market by Region

Chapter 6. Global Vulvovaginal Candidiasis Treatment Market by Region

• 6.1 North America Vulvovaginal Candidiasis Treatment Market
  • 6.1.1 North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel
    • 6.1.1.1 North America Retail Pharmacy Market by Country
    • 6.1.1.2 North America Hospital Pharmacy Market by Country
    • 6.1.1.3 North America Online Pharmacy Market by Country
  • 6.1.2 North America Vulvovaginal Candidiasis Treatment Market by Route of Administration
    • 6.1.2.1 North America Oral Market by Country
    • 6.1.2.2 North America Intravenous Market by Country
    • 6.1.2.3 North America Topical Market by Country
  • 6.1.3 North America Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.1.3.1 North America Fluconazole Market by Country
    • 6.1.3.2 North America Clotrimazole Market by Country
    • 6.1.3.3 North America Terconazole Market by Country
    • 6.1.3.4 North America Terbinafine Market by Country
    • 6.1.3.5 North America Nystatin Market by Country
    • 6.1.3.6 North America Ketoconazole Market by Country
    • 6.1.3.7 North America Others Market by Country
  • 6.1.4 North America Vulvovaginal Candidiasis Treatment Market by Country
    • 6.1.4.1 US Vulvovaginal Candidiasis Treatment Market
      • 6.1.4.1.1 US Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.1.4.1.2 US Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.1.4.1.3 US Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.1.4.2 Canada Vulvovaginal Candidiasis Treatment Market
      • 6.1.4.2.1 Canada Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.1.4.2.2 Canada Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.1.4.2.3 Canada Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.1.4.3 Mexico Vulvovaginal Candidiasis Treatment Market
      • 6.1.4.3.1 Mexico Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.1.4.3.2 Mexico Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.1.4.3.3 Mexico Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.1.4.4 Rest of North America Vulvovaginal Candidiasis Treatment Market
      • 6.1.4.4.1 Rest of North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.1.4.4.2 Rest of North America Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.1.4.4.3 Rest of North America Vulvovaginal Candidiasis Treatment Market by Drug Class
• 6.2 Europe Vulvovaginal Candidiasis Treatment Market
  • 6.2.1 Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel
    • 6.2.1.1 Europe Retail Pharmacy Market by Country
    • 6.2.1.2 Europe Hospital Pharmacy Market by Country
    • 6.2.1.3 Europe Online Pharmacy Market by Country
  • 6.2.2 Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration
    • 6.2.2.1 Europe Oral Market by Country
    • 6.2.2.2 Europe Intravenous Market by Country
    • 6.2.2.3 Europe Topical Market by Country
  • 6.2.3 Europe Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.2.3.1 Europe Fluconazole Market by Country
    • 6.2.3.2 Europe Clotrimazole Market by Country
    • 6.2.3.3 Europe Terconazole Market by Country
    • 6.2.3.4 Europe Terbinafine Market by Country
    • 6.2.3.5 Europe Nystatin Market by Country
    • 6.2.3.6 Europe Ketoconazole Market by Country
    • 6.2.3.7 Europe Others Market by Country
  • 6.2.4 Europe Vulvovaginal Candidiasis Treatment Market by Country
    • 6.2.4.1 Germany Vulvovaginal Candidiasis Treatment Market
      • 6.2.4.1.1 Germany Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.2.4.1.2 Germany Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.2.4.1.3 Germany Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.2.4.2 UK Vulvovaginal Candidiasis Treatment Market
      • 6.2.4.2.1 UK Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.2.4.2.2 UK Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.2.4.2.3 UK Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.2.4.3 France Vulvovaginal Candidiasis Treatment Market
      • 6.2.4.3.1 France Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.2.4.3.2 France Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.2.4.3.3 France Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.2.4.4 Russia Vulvovaginal Candidiasis Treatment Market
      • 6.2.4.4.1 Russia Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.2.4.4.2 Russia Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.2.4.4.3 Russia Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.2.4.5 Spain Vulvovaginal Candidiasis Treatment Market
      • 6.2.4.5.1 Spain Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.2.4.5.2 Spain Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.2.4.5.3 Spain Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.2.4.6 Italy Vulvovaginal Candidiasis Treatment Market
      • 6.2.4.6.1 Italy Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.2.4.6.2 Italy Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.2.4.6.3 Italy Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.2.4.7 Rest of Europe Vulvovaginal Candidiasis Treatment Market
      • 6.2.4.7.1 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.2.4.7.2 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.2.4.7.3 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Drug Class
• 6.3 Asia Pacific Vulvovaginal Candidiasis Treatment Market
  • 6.3.1 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel
    • 6.3.1.1 Asia Pacific Retail Pharmacy Market by Country
    • 6.3.1.2 Asia Pacific Hospital Pharmacy Market by Country
    • 6.3.1.3 Asia Pacific Online Pharmacy Market by Country
  • 6.3.2 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration
    • 6.3.2.1 Asia Pacific Oral Market by Country
    • 6.3.2.2 Asia Pacific Intravenous Market by Country
    • 6.3.2.3 Asia Pacific Topical Market by Country
  • 6.3.3 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.3.3.1 Asia Pacific Fluconazole Market by Country
    • 6.3.3.2 Asia Pacific Clotrimazole Market by Country
    • 6.3.3.3 Asia Pacific Terconazole Market by Country
    • 6.3.3.4 Asia Pacific Terbinafine Market by Country
    • 6.3.3.5 Asia Pacific Nystatin Market by Country
    • 6.3.3.6 Asia Pacific Ketoconazole Market by Country
    • 6.3.3.7 Asia Pacific Others Market by Country
  • 6.3.4 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Country
    • 6.3.4.1 China Vulvovaginal Candidiasis Treatment Market
      • 6.3.4.1.1 China Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.3.4.1.2 China Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.3.4.1.3 China Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.3.4.2 Japan Vulvovaginal Candidiasis Treatment Market
      • 6.3.4.2.1 Japan Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.3.4.2.2 Japan Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.3.4.2.3 Japan Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.3.4.3 India Vulvovaginal Candidiasis Treatment Market
      • 6.3.4.3.1 India Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.3.4.3.2 India Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.3.4.3.3 India Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.3.4.4 South Korea Vulvovaginal Candidiasis Treatment Market
      • 6.3.4.4.1 South Korea Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.3.4.4.2 South Korea Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.3.4.4.3 South Korea Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.3.4.5 Singapore Vulvovaginal Candidiasis Treatment Market
      • 6.3.4.5.1 Singapore Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.3.4.5.2 Singapore Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.3.4.5.3 Singapore Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.3.4.6 Malaysia Vulvovaginal Candidiasis Treatment Market
      • 6.3.4.6.1 Malaysia Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.3.4.6.2 Malaysia Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.3.4.6.3 Malaysia Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.3.4.7 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market
      • 6.3.4.7.1 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.3.4.7.2 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.3.4.7.3 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class
• 6.4 LAMEA Vulvovaginal Candidiasis Treatment Market
  • 6.4.1 LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel
    • 6.4.1.1 LAMEA Retail Pharmacy Market by Country
    • 6.4.1.2 LAMEA Hospital Pharmacy Market by Country
    • 6.4.1.3 LAMEA Online Pharmacy Market by Country
  • 6.4.2 LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration
    • 6.4.2.1 LAMEA Oral Market by Country
    • 6.4.2.2 LAMEA Intravenous Market by Country
    • 6.4.2.3 LAMEA Topical Market by Country
  • 6.4.3 LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.4.3.1 LAMEA Fluconazole Market by Country
    • 6.4.3.2 LAMEA Clotrimazole Market by Country
    • 6.4.3.3 LAMEA Terconazole Market by Country
    • 6.4.3.4 LAMEA Terbinafine Market by Country
    • 6.4.3.5 LAMEA Nystatin Market by Country
    • 6.4.3.6 LAMEA Ketoconazole Market by Country
    • 6.4.3.7 LAMEA Others Market by Country
  • 6.4.4 LAMEA Vulvovaginal Candidiasis Treatment Market by Country
    • 6.4.4.1 Brazil Vulvovaginal Candidiasis Treatment Market
      • 6.4.4.1.1 Brazil Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.4.4.1.2 Brazil Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.4.4.1.3 Brazil Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.4.4.2 Argentina Vulvovaginal Candidiasis Treatment Market
      • 6.4.4.2.1 Argentina Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.4.4.2.2 Argentina Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.4.4.2.3 Argentina Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.4.4.3 UAE Vulvovaginal Candidiasis Treatment Market
      • 6.4.4.3.1 UAE Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.4.4.3.2 UAE Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.4.4.3.3 UAE Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.4.4.4 Saudi Arabia Vulvovaginal Candidiasis Treatment Market
      • 6.4.4.4.1 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.4.4.4.2 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.4.4.4.3 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.4.4.5 South Africa Vulvovaginal Candidiasis Treatment Market
      • 6.4.4.5.1 South Africa Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.4.4.5.2 South Africa Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.4.4.5.3 South Africa Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.4.4.6 Nigeria Vulvovaginal Candidiasis Treatment Market
      • 6.4.4.6.1 Nigeria Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.4.4.6.2 Nigeria Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.4.4.6.3 Nigeria Vulvovaginal Candidiasis Treatment Market by Drug Class
    • 6.4.4.7 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market
      • 6.4.4.7.1 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.4.4.7.2 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.4.4.7.3 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class

Chapter 7. Company Profiles

• 7.1 Bayer AG
  • 7.1.1 Company Overview
  • 7.1.2 Financial Analysis
  • 7.1.3 Segmental and Regional Analysis
  • 7.1.4 Research & Development Expense
• 7.2 Pfizer, Inc.
  • 7.2.1 Company Overview
  • 7.2.2 Financial Analysis
  • 7.2.3 Regional & Segmental Analysis
  • 7.2.4 Research & Development Expense
• 7.3 Bristol Myers Squibb Company
  • 7.3.1 Company Overview
  • 7.3.2 Financial Analysis
  • 7.3.3 Regional Analysis
  • 7.3.4 Research & Development Expenses
• 7.4 Astellas Pharma, Inc.
  • 7.4.1 Company Overview
  • 7.4.2 Financial Analysis
  • 7.4.3 Regional Analysis
  • 7.4.4 Research & Development Expense
• 7.5 Mycovia Pharmaceuticals, Inc. (NovaQuest Capital Management, LLC)
  • 7.5.1 Company Overview
  • 7.5.2 Recent strategies and developments:
    • 7.5.2.1 Trials and Approvals:
• 7.6 Basilea Pharmaceutica Ltd.
  • 7.6.1 Company Overview
  • 7.6.2 Financial Analysis
  • 7.6.3 Segmental and Regional Analysis
  • 7.6.4 Research & Development Expenses
• 7.7 Scynexis, Inc.
  • 7.7.1 Company Overview
  • 7.7.2 Financial Analysis
  • 7.7.3 Research & Development Expenses
  • 7.7.4 Recent strategies and developments:
    • 7.7.4.1 Trials and Approvals:
• 7.8 Grupo Ferrer Internacional S.A.
  • 7.8.1 Company Overview